Thryv insider trades show tax‑driven sales but sustained buying—insiders keep confidence, while investors should watch market shifts and product risks for long‑term value.
Thryv insider sales reveal routine tax‑withholding moves, not a confidence drop – investors can gauge the stock’s future from clinical milestones, not trades.